Article thumbnail

Imaging genetics of schizophrenia

By Andreas Meyer-Lindenberg

Abstract

Recent years have seen an explosive growth of interest in the application of imaging genetics to understand neurogenetic mechanisms of schizophrenia. Imaging genetics applies structural and functional neuroimaging to study subjects carrying genetic risk variants that relate to a psychiatric disorder. We review selected aspects of this literature, starting with a widely studied candidate gene - the catechol-0-methyltransferase gene (COMT)- discussing other candidate genes in the dopaminergic system, and then discussing variants with genome-wide support. In future perspectives, approaches to characterize epistatic effects, the identification of new risk genes through forward-genetic approaches using imaging phenotypes, and the study of rare structural variants are considered

Topics: Translational Research
Publisher: Les Laboratoires Servier
OAI identifier: oai:pubmedcentral.nih.gov:3181991
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. 22q11.2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia.
  2. A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain.
  3. A polygenic theory of schizophrenia.
  4. Additive effects of genetic variation in dopamine regulating genes on working memory cortical activity in human brain.
  5. Allelic variation in RGS4 impacts functional and structural connectivity in the human brain.
  6. Bias in genetic association studies: effects of research location and resources. Psychol Med.
  7. Catechol-O-methyltransferase (COMT) val158met genotype is associated with BOLD response as a function of task characteristic.
  8. (1998). Catechol-O-methyltransferasedeficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior.
  9. CatecholO-methyl transferase Val158Met gene polymorphism in schizophrenia: working memory, frontal lobe MRI morphology and frontal cerebral blood flow. Mol Psychiatry.
  10. (1992). Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1----q11.2. Genomics.
  11. Combining fMRI and SNP data to investigate connections between brain function and genetics using parallel ICA. Hum Brain Mapp.
  12. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder.
  13. Common variants conferring risk of schizophrenia.
  14. Common variants on chromosome 6p22.1 are associated with schizophrenia.
  15. COMT val158met genotype affects recruitment of neural mechanisms supporting fluid intelligence. Cereb Cortex.
  16. COMT val158met modulates association between brain white matter architecture and IQ.
  17. Consortium. Rare chromosomal deletions and duplications increase risk of schizophrenia.
  18. (2010). Distribution of catechol-Omethyltransferase expression in human central nervous system.
  19. Effect of abstinence challenge on brain function and cognition in smokers differs by COMT genotype. Mol Psychiatry.
  20. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia.
  21. Epistasis between dopamine regulating genes identifies a nonlinear response of the human hippocampus during memory tasks. Biol Psychiatry.
  22. (2007). fMRI evidence for functional epistasis between COMT and RGS4. Mol Psychiatry.
  23. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain.
  24. (2008). Functional polymorphisms in PRODH are associated with risk and protection for schizophrenia and fronto-striatal structure and function. PLoS Genet.
  25. Functional variants of the dopamine receptor D2 gene modulate prefronto-striatal phenotypes in schizophrenia.
  26. Genetic evidence implicating DARPP-32 in human frontostriatal structure, function, and cognition.
  27. Genetic variation in AKT1 is linked to dopamine-associated prefrontal cortical structure and function in humans.
  28. Genetic variation in components of dopamine neurotransmission impacts ventral striatal reactivity associated with impulsivity. Mol Psychiatry.
  29. Genome-wide analysis reveals novel genes influencing temporal lobe structure with relevance to neurodegeneration in Alzheimer's disease.
  30. High-performance liquid chromatography-fluorescent assay of catechol-O-methyltransferase activity in rat brain.
  31. (1991). Human catechol-O-methyltransferase: cloning and expression of the membrane-associated form.
  32. Identification of loci associated with schizophrenia by genome-wide association and follow-up.
  33. Identifying gene regulatory networks in schizophrenia.
  34. Impact of complex genetic variation in COMT on human brain function. Mol Psychiatry.
  35. Impact of interacting functional variants in COMT on regional gray matter volume in human brain.
  36. Influence of COMT gene polymorphism on fMRI-assessed sustained and transient activity during a working memory task.
  37. Influence of SLC6A3 and COMT variation on neural activation during response inhibition.
  38. Interaction of COMT (Val(108/158)Met) genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia.
  39. Large recurrent microdeletions associated with schizophrenia.
  40. Microdeletion 15q13.3: a locus with incomplete penetrance for autism, mental retardation, and psychiatric disorders.
  41. Neural mechanisms of a genomewide supported psychosis variant.
  42. Neural substrates of pleiotropic action of genetic variation in COMT: a meta-analysis. Mol Psychiatry.
  43. Neuropsychological profile and neuroimaging in patients with 22Q11.2 Deletion Syndrome: a review. Child Neuropsychol.
  44. on prefrontal function in healthy subjects.
  45. Psychosis susceptibility gene ZNF804A and cognitive performance in schizophrenia. Arch Gen Psychiatry.
  46. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia.
  47. Relationship of catechol-Omethyltransferase variants to brain structure and function in a population at high risk of psychosis. Biol Psychiatry.
  48. RGS4 mRNA expression in postmortem human cortex is associated with COMT Val158Met genotype and COMT enzyme activity. Hum Mol Genet.
  49. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies.
  50. The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia.
  51. The catechol-Omethyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes.
  52. The COMT val158met polymorphism and brain morphometry in healthy young adults.
  53. The endophenotype concept in psychiatry: etymology and strategic intentions.
  54. The molecular genetics of schizophrenia: new findings promise new insights. Mol Psychiatry.
  55. Variants in the catechol-o-methyltransferase (COMT) gene are associated with schizophrenia in Irish high-density families. Mol Psychiatry.
  56. Variation in dopamine genes influences responsivity of the human reward system.